Structure-activity relationship of the agonist-antagonist transition on the type 1 angiotensin II receptor; the search for inverse agonists

Advances in Experimental Medicine and Biology

Volumn 396, Issue , 1996, Pages 131-143

  Pérodin, Jacqueline ^a   Bossé, Roger ^a   Gagnon, Sylvain ^a   Zhou, Li Ming ^a   Bouley, Richard ^a   Leduc, Richard ^a   Escher, Emanuel ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CATTLE; COMPETITIVE INHIBITION; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; GENE LOCUS; MOLECULAR RECOGNITION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

EID: 0029886118     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1376-0_14     Document Type: Article

References (39)

1. 1B-Adrenergic Receptor by All Amino Acid Substitution at a Single Site, J. Biol. Chem. 267 (1992) -1433.
2. 1B-adrenergic receptor enhances mitogenesis and tumorigenecity, Proc. Natl. Acad. Sci. USA 88 (1991) 11354-11358.
3. 2-Adrenergic Receptor, J. Biol. Chem. 268 (1993) 4625-4636.
4. Robinson, P.R., Cohen, G.B. Zhukovsky, E.A. and Oprian, D.D., Constitutively active mutants of rhodopsin, Neuron 9 (1992) 719-725.
5. Schutz, W. and Freissmuth, M., Reverse intrinsic activity of antagonists on G protein-coupled receptors, Trends Pharmacol. Sci. 13 (1992) 376-380.
6. Costa, T., Ogino, Y., Munson, P.J., Onaran, H.O. and Rodbard, D., Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: Thermodynamic interpretation of negative antagonism and receptor activity in the absence of ligand, Mol. Pharmacol. 41 (1992) 549-560.
7. Barker, E.L., Westphal, R.S. Schmidt, D. and Sanders-Bush, E., Constitutively active 5′-hydroxytryptamine 2C receptors reveal novel inverse agonist activity of receptor ligands, J. Biol. Chem. 269 (1994) -11690.
8. Chidiac, P., Hebert, T., Valiquette, M., Dennis, M. and Bouvier, M., Inverse agonist activity of ß-adrenergic antagonists, Mol. Pharmacol. 45 (1994) 490-499.
9. Parma, J., Duprez, L., Van Sade, J., Cochaux, P., Gervy, P., Mockel, J., Dumont, J. and Vassart, G., Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas, Nature 365 (1993) -651.
10. Shenker, A., Laue, L., Kosug, S., Merendino, J.J., Minegishi, T. and Cutler, J.B., A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty, Nature 365 (1993) 652-654.
11. Young, D., Waitches, G., Birchmeier, C., Fasano, O. and Wigler, M., Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains, Cell 45 (1986) -719.
12. Regoli, D., Park, W.K. and Rioux, F., Pharmacology of Angiotensin, Pharmacological Reviews 26 (1974) -123.
13. 1) Receptor, Thrombosis and Haemostasis 70 (1993) 188-192.
14. Timmermans, P.B.M.W.M., Wong, P.C., Chiu, A.T., Herblin, W.E., Benfield, P., Carini, D.J., Lee, R.J., Wexler, R.R., Saye, J.A.M. and Smith, R.D., Angiotensin II Receptors and Angiotensin II Receptor Antagonists, Pharmacological Reviews 45 (1993) 205-247.
15. Dudley, D.T., Panek, R.L., Major, T.C., Lu, G.H., Burns, R.F., Klinkefus, B.A., Hodges, J.C. and Weishaar, R.E., Subclasses of angiotensin II binding sites and their functional significance, Mol. Pharmacol. 38 (1990) 370-377.
16. 2 receptor stimulates protein tyrosin phosphatase activity and mediates inhibition of particulate guanylate eyclase, Biochem. Biophys. Res. Commun. 183 (1992) 206- 211.
17. Kambayashi, Y., Bardhan, S., Takahashi, K., Tsuzuki, S. Inui, H., Hamakubo and Inagami, T., Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition, J. Biol. Chem. 268 (1993) 24543-24546.
18. Bernier, S.G., Fournier, A. and Guillemette, G., A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes, Eur. J. Pharmacol. 271 (1994) 55-63.
19. 2 receptor populations in murine neuroblastoma N1E-115 cells, J. Neurochem. 62 (1994) -2115.
20. 2 binding sites observed in PC12 cells after confluency, (to be published).
21. Murphy, T.J., Nakamura, Y., Takeuchi, K. and Alexander, R.W., A cloned angiotensin receptor isoform from the turkey adrenal gland is pharmacologically distinct from mammalian angiotensin receptors, Mol. Pharmacol. 44 (1993) 1-7.
22. Ji, H., Sanberg, K., Zhang, Y. Catt, K.J., Molecualr cloning, sequencing and functional expression of an amphibian angiotensin II receptor, Biochem. Biophys. Res. Commun. 194 (1993) 756-762.
23. Nishimura, H., Walker, O.E., Patton, C.M., Madison, A.T., Chiu, A.T. and Keiser, J., Novel angiotensin receptor subtypes in fowl, Am. J. Physiol. 267 (1994) R1174-R1181.
24. 1 Receptor Antagonist, J. Pharmacol. Experm. Therap. 259 (1991) 861-870.
25. Chang, R.S.L., Siegl, P.K.S., Clineschmidt, B.V., Mantlo, N.B., Chakravarty, P.K., Greenlee, W.J., Patchett, A.A. and Lotti, V.J., In Vitro Pharmacology of L-158,809, a New Highly Potent and Selective Angiotensin II Receptor Antagonist, J. Pharmacol. Experm. Therap. 262 (1992) 133-138.
26. 1 receptor, J. Biol. Chem. 270 (1995) 1493-1496.
27. Pérodin, J and Escher, E. (unpuplished results).
28. Fraker, P.J. and Speck, J.C., Protein and cell iodination with a sparingly soluble chloroamine, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoloryl, Biochem. Biophys. Res. Commun. 80 (1978) 849-857.
29. Merrifield, R.B., Solid-phase peptide synthesis. I: The synthesis of a tetrapeptide, J. Am. Chem. Soc., 85 (1963) 2149-2154.
30. Leduc, R., Bernier, M. and Escher, E., Angiotensin-II Analogues. I: Synthesis and Incorporation of the Halogenated Amino Acids 3-(4′-Iodophenyl)alanine, 3-(3′,5′-Dibromo-4′-chlorophenyl)alanine. 3-(3′,4′,5′-Tribromophenyl)alanine, and 3-(2′,3′,4′,5′,6′-Pentabromophenyl)alanine, Helvetica Chimica acta 66 (1983) 960-970.
31. 3)Phe, Helvetica Chimica acta 66 (1983) 1355-1365.
32. Quang, K.D., Thanei, P., Caviezel, M. and Schwyzer, R., The Synthesis of (S)-(+)-2-Amino-3-(1-adamantyl)-propionic Acid (L-(+)-Adamantylalanine, Ada) as a "Fat" or "Super" Analogue of Leucine and Phenylalanine, Helvetica Chimica acta 62 (1979) 956-964.
33. Tartar, A., Demarly, A., Sergheraert, C. and Escher, E., Metallocenic angiotensin II analogues, "Peptides '83" V. Hruby (Ed) Pierce Corp., Rockford, III, 1984. pp. 377-380.
34. Hsieh, K.H., LaHann, T.R. and Speth, R.C., Topographic Probes of Angiotensin and Receptor: Potent Angiotensin II Agonist Containing Diphenylalanine and Long-Acting Antagonists Containing Biphenylalanine and 2-Indan Amino Acid in Position 8, J. Med. Chem. 32 (1989) 898-903.
35. Samanen, J., Narindray, D., Adams Jr. W., Cash, T., Yellin, T. and Regoli, D., Effects of D-Amino Acid Substitution on Antagonist Activities of Angiotensin II Analogues. J. Med. Chem. 31 (1988) 510-516.
36. Leukart, O., Caviezel, M., Eberie, A., Escher, E., Tun-Kyi, A. and Schwyzer, R., L-o-Carboranyl, a Boron Analogue of Phenylalanine, Helvetica Chimica Acta 59 (1976) 2184-2187.
37. Hansch, C., Leo, A., Unger, S.H., Kim, K.H., Nikaitani, D. and Lien, E.J., "Aromatic" Substituent Constants for Structure-Activity Correlations, J. Med. Chem. 16 (1973) 1207-1216.
38. Holck, M., Bossé, R., Fischli, W., Gerold, H. and Escher, E., An Angiotensin II antagonist with strongly prolonged action, Biochem. Biophys. Res. Commun. 160 (1989) 1350-1356.
39. Bossé, R., Gerold, H., Fischli, W., Holck, M. and Escher, E., An angiotensin antagonist with prolonged action and antihypertensive properties, J. Cardiovasc. Pharmacol. 16 (1990) S50-S55.